Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 171,700 | 166,100 | 173,300 | 171,300 | 169,400 |
| Cost of Goods | 76,100 | 71,300 | 78,300 | 75,800 | 71,600 |
| Gross Profit | 95,600 | 94,800 | 95,000 | 95,500 | 97,800 |
| Operating Expenses | 89,400 | 91,100 | 84,100 | 95,100 | 100,500 |
| Operating Income | 6,300 | 4,000 | 11,200 | 1,200 | -2,100 |
| Interest Expense | 3,100 | 3,100 | 3,300 | 4,700 | 3,500 |
| Other Income | 3,000 | 600 | 1,000 | 900 | 500 |
| Pre-tax Income | 6,200 | 1,500 | 8,900 | -2,600 | -5,100 |
| Income Tax | 1,900 | 1,000 | -2,100 | 6,200 | -800 |
| Net Income Continuous | 4,300 | 500 | 11,000 | -8,800 | -4,300 |
| Net Income Discontinuous | -2,500 | -1,400 | -500 | 5,100 | -63,800 |
| Net Income | $1,800 | $-900 | $10,500 | $-3,700 | $-68,100 |
| EPS Basic Total Ops | 0.04 | -0.02 | 0.23 | -0.08 | -1.46 |
| EPS Basic Continuous Ops | 0.09 | 0.01 | 0.24 | -0.19 | -0.09 |
| EPS Basic Discontinuous Ops | -0.05 | -0.03 | -0.01 | 0.11 | -1.37 |
| EPS Diluted Total Ops | 0.04 | -0.02 | 0.23 | -0.08 | -1.46 |
| EPS Diluted Continuous Ops | 0.09 | 0.01 | 0.24 | -0.19 | -0.09 |
| EPS Diluted Discontinuous Ops | -0.05 | -0.03 | -0.01 | 0.11 | -1.37 |
| EPS Diluted Before Non-Recurring Items | 0.34 | 0.22 | 0.36 | 0.30 | 0.24 |
| EBITDA(a) | $17,600 | $15,400 | $-36,400 | $12,200 | $68,500 |